Recruiting PHASE2 INTERVENTIONAL 2-arm NCT06286397

Topical Anti-Androgens in Pilonidal Sinus Disease

Sponsor: University of Pennsylvania

Conditions Pilonidal Cyst Pilonidal Disease Pilonidal Disease of Natal Cleft Pilonidal Sinus

Interventions 1% Clascoterone Vehicle Cream

Updated 7 times since 2024 Last updated: Feb 25, 2026 Started: Jan 10, 2025 Primary completion: Jan 1, 2028 Completion: Jan 1, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06286397, this PHASE2 trial focuses on Pilonidal Cyst and Pilonidal Disease and remains actively recruiting participants. Sponsored by University of Pennsylvania, it has been updated 7 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Feb 2026 — Present [monthly]

Recruiting PHASE2
Feb 2025 — Feb 2026 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting
Nov 2024 — Feb 2025 [monthly]

Not Yet Recruiting PHASE2
Sep 2024 — Nov 2024 [monthly]

Not Yet Recruiting PHASE2
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting PHASE2

▶ Show 2 earlier versions

Apr 2024 — Jul 2024 [monthly]

Not Yet Recruiting PHASE2
Mar 2024 — Apr 2024 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Pennsylvania

Data source: University of Pennsylvania

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Philadelphia, United States